Bluelinea Société Anonyme (ALBLU.PA)

EUR 0.85

(2.41%)

EBITDA Summary of Bluelinea Société Anonyme

Bluelinea Société Anonyme's latest annual EBITDA in 2023 was -323.98 EUR , down -100.05% from previous year.
Bluelinea Société Anonyme's latest quarterly EBITDA in 2024 Q2 was -1.14 Million EUR , down 0.0% from previous quarter.
Bluelinea Société Anonyme reported an annual EBITDA of 74.36 Thousand EUR in 2022, up 127.94% from previous year.
Bluelinea Société Anonyme reported an annual EBITDA of -2.61 Million EUR in 2021, down -25.72% from previous year.
Bluelinea Société Anonyme reported a quarterly EBITDA of -1.15 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Bluelinea Société Anonyme reported a quarterly EBITDA of N/A for 2023 FY, down -152.17% from previous quarter.

Annual EBITDA Chart of Bluelinea Société Anonyme (2023 - 2011)

Historical Annual EBITDA of Bluelinea Société Anonyme (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	-323.98 EUR	-100.05%
2022	74.36 Thousand EUR	127.94%
2021	-2.61 Million EUR	-25.72%
2020	-1.62 Million EUR	-1.15%
2019	-1.72 Million EUR	-20.02%
2018	-1.8 Million EUR	-79015.52%
2017	-2.44 Million EUR	30.12%
2016	-2.36 Million EUR	-100.69%
2015	-1.19 Million EUR	99.93%
2014	-1.92 Million EUR	-79.14%
2013	-1.08 Million EUR	-81.45%
2012	-477.29 Thousand EUR	-106.46%
2011	-323.79 Thousand EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-1.14 Million EUR	0.0%
2023 Q2	-1.15 Million EUR	0.0%
2023 FY	- EUR	-152.17%
2023 Q4	-454 Thousand EUR	0.0%
2022 Q4	384.42 Thousand EUR	0.0%
2022 FY	- EUR	127.94%
2022 Q2	236.52 Thousand EUR	0.0%
2021 FY	- EUR	-25.72%
2021 Q4	-932.73 Thousand EUR	0.0%
2021 Q2	-1.28 Million EUR	0.0%
2020 Q2	-912.03 Thousand EUR	0.0%
2020 FY	- EUR	-1.15%
2020 Q4	-855.78 Thousand EUR	0.0%
2019 Q4	-1715.61 EUR	0.0%
2019 Q2	-742.70 EUR	0.0%
2019 FY	- EUR	-20.02%
2018 Q2	101 Thousand EUR	0.0%
2018 Q4	-4.29 Million EUR	0.0%
2018 FY	- EUR	-79015.52%
2017 Q4	-806.00 EUR	0.0%
2017 FY	- EUR	30.12%
2017 Q2	-1246.95 EUR	0.0%
2016 FY	- EUR	-100.69%
2016 Q2	-1037.06 EUR	0.0%
2016 Q4	-1596.91 EUR	0.0%
2015 FY	- EUR	99.93%
2015 Q2	-1218.85 EUR	0.0%
2015 Q4	-93.60 EUR	0.0%
2014 Q1	-494.61 Thousand EUR	0.0%
2014 Q2	-1005.67 EUR	99.8%
2014 Q4	-1047.56 EUR	99.79%
2014 FY	- EUR	-79.14%
2014 Q3	-494.61 Thousand EUR	-49082.88%
2013 Q3	-285.86 Thousand EUR	0.0%
2013 Q1	-285.86 Thousand EUR	0.0%
2013 Q4	-494.61 Thousand EUR	-73.02%
2013 FY	- EUR	-81.45%
2013 Q2	-285.86 Thousand EUR	0.0%
2012 FY	- EUR	-106.46%
2012 Q2	-182.36 Thousand EUR	0.0%
2012 Q4	-285.86 Thousand EUR	-56.76%
2012 Q1	-182.36 Thousand EUR	0.0%
2012 Q3	-182.36 Thousand EUR	0.0%
2011 Q2	-81.64 Thousand EUR	0.0%
2011 FY	- EUR	0.0%
2011 Q3	-81.64 Thousand EUR	0.0%
2011 Q1	-81.64 Thousand EUR	0.0%
2011 Q4	-182.36 Thousand EUR	-123.37%
2010 Q4	-81.64 Thousand EUR	0.0%

Peer EBITDA Comparison of Bluelinea Société Anonyme

Name	EBITDA	EBITDA Difference
Affluent Medical SA	-13.34 Million EUR	99.998%
Carmat SA	-50.45 Million EUR	99.999%
Diagnostic Medical Systems S.A.	-7.05 Million EUR	99.995%
Euromedis Groupe	-4.43 Million EUR	99.993%
Eurobio Scientific Société anonyme	18.98 Million EUR	100.002%
Ikonisys S.A.	-2.34 Million EUR	99.986%
Implanet S.A.	-5.07 Million EUR	99.994%
Median Technologies SA	-19.58 Million EUR	99.998%
SpineGuard SA	-3.49 Million EUR	99.991%
Theraclion SA	-4.48 Million EUR	99.993%
Euroapi S.A.	-155.39 Million EUR	100.0%
Guerbet SA	98.83 Million EUR	100.0%
Ion Beam Applications SA	12.53 Million EUR	100.003%
Koninklijke Philips N.V.	1.04 Billion EUR	100.0%
Sequana Medical NV	-29.13 Million EUR	99.999%